CRON Cronos Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CRON

Price (delayed)

$1.94

Market cap

$738.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.45

Enterprise value

-$25M

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology ...

Highlights
Cronos Group's EPS has surged by 58% YoY and by 25% QoQ
The net income has surged by 57% year-on-year and by 24% since the previous quarter
Cronos Group's gross profit has soared by 168% YoY but it has decreased by 15% from the previous quarter
The company's gross margin has surged by 155% YoY but it fell by 13% QoQ
The company's quick ratio fell by 45% QoQ and by 30% YoY
Cronos Group's equity has decreased by 14% YoY and by 4.2% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://thecronosgroup.com

Key stats

What are the main financial stats of CRON
Market
Shares outstanding
380.58M
Market cap
$738.32M
Enterprise value
-$25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.64
Price to sales (P/S)
7.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.27
Earnings
Revenue
$91.9M
EBIT
-$157.1M
EBITDA
-$143.97M
Free cash flow
-$92.4M
Per share
EPS
-$0.45
Free cash flow per share
-$0.24
Book value per share
$3.02
Revenue per share
$0.24
TBVPS
$3.13
Balance sheet
Total assets
$1.21B
Total liabilities
$72.05M
Debt
$1.33M
Equity
$1.14B
Working capital
$892.04M
Liquidity
Debt to equity
0
Current ratio
14.1
Quick ratio
13.44
Net debt/EBITDA
5.3
Margins
EBITDA margin
-156.7%
Gross margin
13%
Net margin
-183.6%
Operating margin
-135.8%
Efficiency
Return on assets
-13.1%
Return on equity
-13.6%
Return on invested capital
-34.3%
Return on capital employed
-13.7%
Return on sales
-170.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CRON stock price

How has the Cronos Group stock price performed over time
Intraday
0.52%
1 week
-0.51%
1 month
-7.62%
1 year
-51.38%
YTD
-23.62%
QTD
-23.62%

Financial performance

How have Cronos Group's revenue and profit performed over time
Revenue
$91.9M
Gross profit
$11.97M
Operating income
-$124.84M
Net income
-$168.73M
Gross margin
13%
Net margin
-183.6%
Cronos Group's gross profit has soared by 168% YoY but it has decreased by 15% from the previous quarter
The company's gross margin has surged by 155% YoY but it fell by 13% QoQ
The operating margin has soared by 82% YoY and by 50% QoQ
The company's operating income has surged by 78% YoY and by 52% QoQ

Growth

What is Cronos Group's growth rate over time

Valuation

What is Cronos Group stock price valuation
P/E
N/A
P/B
0.64
P/S
7.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.27
Cronos Group's EPS has surged by 58% YoY and by 25% QoQ
The price to book (P/B) is 80% lower than the 5-year quarterly average of 3.2 and 29% lower than the last 4 quarters average of 0.9
Cronos Group's equity has decreased by 14% YoY and by 4.2% from the previous quarter
The price to sales (P/S) is 92% lower than the 5-year quarterly average of 102.9 and 36% lower than the last 4 quarters average of 12.4
Cronos Group's revenue has increased by 23% YoY but it has decreased by 3.1% QoQ

Efficiency

How efficient is Cronos Group business performance
Cronos Group's return on sales has surged by 69% YoY and by 32% QoQ
The company's return on invested capital has surged by 61% YoY and by 31% QoQ
CRON's ROE has soared by 51% YoY and by 22% QoQ
The company's return on assets rose by 47% YoY and by 22% QoQ

Dividends

What is CRON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRON.

Financial health

How did Cronos Group financials performed over time
The total liabilities has soared by 56% QoQ and by 14% YoY
The company's quick ratio fell by 45% QoQ and by 30% YoY
The company's debt is 100% lower than its equity
The company's debt has shrunk by 51% YoY and by 30% QoQ
Cronos Group's equity has decreased by 14% YoY and by 4.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.